tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market
Advertisement

Traws Pharma (TRAW) Technical Analysis

Compare
1,856 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Traws Pharma’s (TRAW) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Traws Pharma is a Sell.
Traws Pharma’s (TRAW) 20-Day exponential moving average is 1.55, while Traws Pharma’s (TRAW) share price is $1.64, making it a Buy.
Traws Pharma’s (TRAW) 50-Day exponential moving average is 1.67, while Traws Pharma’s (TRAW) share price is $1.64, making it a Sell.

Traws Pharma (TRAW) Pivot Points

Jul 22, 2025, 06:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.47
1.52
1.56
1.62
1.66
1.71
1.75
Fibonacci
1.52
1.56
1.58
1.62
1.65
1.68
1.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Traws Pharma (TRAW) Moving Averages

Jul 22, 2025, 06:31 PM
Period
Simple
Exponential
MA5
1.58Buy
1.60Buy
MA10
1.56Buy
1.57Buy
MA20
1.52Buy
1.55Buy
MA50
1.49Buy
1.67Sell
MA100
1.86Sell
2.37Sell
MA200
3.94Sell
4.10Sell
Traws Pharma’s (TRAW) 10-Day exponential moving average is 1.57, while Traws Pharma’s (TRAW) share price is $1.64, making it a Buy.
Traws Pharma’s (TRAW) 100-Day exponential moving average is 2.37, while Traws Pharma’s (TRAW) share price is $1.64, making it a Sell.
Traws Pharma’s (TRAW) stock price is $1.64 and Traws Pharma’s (TRAW) 50-day simple moving average is 1.49, creating a Buy signal.
Traws Pharma’s (TRAW) stock price is $1.64 and Traws Pharma’s (TRAW) 100-day simple moving average is 1.86, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $1.64 and Traws Pharma’s (TRAW) 200-day simple moving average is 3.94, creating a Sell signal.

Traws Pharma (TRAW) Technical Indicators

Jul 22, 2025, 06:31 PM
Name
Value
Implied Action
RSI (14)
56.69
Neutral
STOCH (9,6)
82.98
Sell
STOCHRSI (14)
85.75
Sell
MACD (12,26)
0.01
Sell
ADX (14)
16.17
Buy
Williams %R
-12.28
Sell
CCI (14)
143.57
Sell
ATR (14)
0.12
-
Ultimate Oscillator
50.25
Neutral
ROC
10.81
Buy
Traws Pharma’s (TRAW) Relative Strength Index (RSI) is 56.69, creating a Neutral signal.
Traws Pharma’s (TRAW) Trend Strength Indicator (ADX) is 16.17, creating a Buy signal.
Traws Pharma’s (TRAW) Commodity Channel Index (CCI) is 143.57, creating a Sell signal.
Traws Pharma’s (TRAW) Price Rate of Change (ROC) is 10.81, creating a Buy signal.

FAQ

Is TRAW a Buy, Hold, or Sell?
Based on TRAW’s technical indicators, TRAW is a Hold.
    What is TRAW’s RSI (14)?
    TRAW’s RSI (14) is 56.69, which suggests TRAW is a Neutral.
      What is TRAW’s MACD?
      TRAW’s MACD is 0.01, which suggests TRAW is a Sell.
        What is TRAW’s 5-day moving average?
        TRAW’s 5-day moving average is 1.58, which suggests TRAW is a Buy.
          What is TRAW’s 20-day moving average?
          TRAW 20-day moving average is 1.52, which suggests TRAW is a Buy.
            What is TRAW’s 50-day moving average?
            TRAW’s 50-day moving average is 1.49, which suggests TRAW is a Buy.
              What is TRAW’s 200-day moving average?
              TRAW’s 200-day moving average is 3.94, which suggests TRAW is a Sell.
                What is TRAW’s Williams % R (14)?
                TRAW’s Williams % R (14) is -12.28, which suggests TRAW is a Sell.
                  What is TRAW’s CCI (14)?
                  TRAW’s CCI (14) is 143.57, which suggests TRAW is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis